(PETV) MINNEAPOLIS, Sept. 02, 2025 (GLOBE NEWSWIRE) -- PetVivo Animal Health, Inc., a wholly-owned subsidiary of PetVivo Holdings, Inc. (OTCQX: PETV; OTCID: PETVW) (collectively referred to herein as "PetVivo"), is an emerging biomedical device company focused on the commercialization of innovative medical devices and other therapeutics for equine and companion animals, announced today it has entered into a definitive distribution agreement with Nupsala Limited (“Nupsala”). Nupsala will inventory, market and promote PetVivo’s veterinary medical device, Spryng® with OsteoCushion® technology, throughout the United Kingdom. Nupsala’s sales and marketing activities will commence on September 1, 2025.
Related Questions
How will the distribution agreement with Nupsala Limited affect PETV's revenue and earnings forecasts?
What is the market size and growth potential for Spryng® with OsteoCushion® technology in the UK veterinary market?
What are the execution risks and timelines associated with Nupsala's rollout and inventory management?